A Computational Approach to Epilepsy Treatment: An AI-optimized Global Natural Product Prescription System

• URL: http://arxiv.org/abs/2505.09643v1
• Date: Sat, 10 May 2025 08:14:20 GMT
• Title: A Computational Approach to Epilepsy Treatment: An AI-optimized Global Natural Product Prescription System
• Authors: Zhixuan Wang,
• Abstract summary: Epilepsy is a prevalent neurological disease with millions of patients worldwide.<n>Many have turned to alternative medicine due to limited efficacy and side effects of conventional antiepileptic drugs.<n>We developed a computational approach to optimize herbal epilepsy treatment through AI-driven analysis of global natural products.
• Score: 0.5439020425819
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Epilepsy is a prevalent neurological disease with millions of patients worldwide. Many patients have turned to alternative medicine due to the limited efficacy and side effects of conventional antiepileptic drugs. In this study, we developed a computational approach to optimize herbal epilepsy treatment through AI-driven analysis of global natural products and statistically validated randomized controlled trials (RCTs). Our intelligent prescription system combines machine learning (ML) algorithms for herb-efficacy characterization, Bayesian optimization for personalized dosing, and meta-analysis of RCTs for evidence-based recommendations. The system analyzed 1,872 natural compounds from traditional Chinese medicine (TCM), Ayurveda, and ethnopharmacological databases, integrating their bioactive properties with clinical outcomes from 48 RCTs covering 48 epilepsy conditions (n=5,216). Using LASSO regression and SHAP value analysis, we identified 17 high-efficacy herbs (e.g., Gastrodia elata [using \'e for accented characters], Withania somnifera), showing significant seizure reduction (p$<$0.01, Cohen's d=0.89) with statistical significance confirmed by multiple testing (p$<$0.001). A randomized double-blind validation trial (n=120) demonstrated 28.5\% greater seizure frequency reduction with AI-optimized herbal prescriptions compared to conventional protocols (95\% CI: 18.7-37.3\%, p=0.003).

Related papers

• Urinary Tract Infection Detection in Digital Remote Monitoring: Strategies for Managing Participant-Specific Prediction Complexity [43.108040967674185]
  Urinary tract infections (UTIs) are a significant health concern, particularly for people living with dementia (PLWD)<n>This study builds on previous work that utilised machine learning (ML) to detect UTIs in PLWD.
  arXiv  Detail & Related papers  (2025-02-18T12:01:55Z)
• Artificial Intelligence-Based Triaging of Cutaneous Melanocytic Lesions [0.8864540224289991]
  Pathologists are facing an increasing workload due to a growing volume of cases and the need for more comprehensive diagnoses. We developed an artificial intelligence (AI) model for triaging cutaneous melanocytic lesions based on whole slide images.
  arXiv  Detail & Related papers  (2024-10-14T13:49:04Z)
• An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results [0.10051474951635876]
  Adverse drug events (ADEs) are a major safety issue in clinical trials.<n>We introduce CT-ADE, a dataset for multilabel ADE prediction in monopharmacy treatments.
  arXiv  Detail & Related papers  (2024-04-19T12:04:32Z)
• Evaluating the Effectiveness of Artificial Intelligence in Predicting Adverse Drug Reactions among Cancer Patients: A Systematic Review and Meta-Analysis [0.0]
  This study aims to assess the performance of artificial intelligence models in predicting adverse drug reactions in patients with cancer. The use of AI in cancer treatment shows great potential, with models demonstrating high specificity and sensitivity in predicting ADRs. However, standardized research and multicenter studies are needed to improve the quality of evidence.
  arXiv  Detail & Related papers  (2024-04-06T11:20:28Z)
• Institutional-Level Monitoring of Immune Checkpoint Inhibitor IrAEs Using a Novel Natural Language Processing Algorithmic Pipeline [0.0]
  Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but can result in severe immune-related adverse events (IrAEs) This study conducted an analysis of clinical notes from patients who received ICIs at the Tel Aviv Sourasky Medical Center. By employing a Natural Language Processing algorithmic pipeline, we systematically identified seven common or severe IrAEs.
  arXiv  Detail & Related papers  (2024-03-09T19:18:27Z)
• Deep-Learning Tool for Early Identifying Non-Traumatic Intracranial Hemorrhage Etiology based on CT Scan [40.51754649947294]
  The deep learning model was developed with 1868 eligible NCCT scans with non-traumatic ICH collected between January 2011 and April 2018. The model's diagnostic performance was compared with clinicians's performance. The clinicians achieve significant improvements in the sensitivity, specificity, and accuracy of diagnoses of certain hemorrhage etiologies with proposed system augmentation.
  arXiv  Detail & Related papers  (2023-02-02T08:45:17Z)
• Neural Bandits for Data Mining: Searching for Dangerous Polypharmacy [63.135687276599114]
  Some polypharmacies, deemed inappropriate, may be associated with adverse health outcomes such as death or hospitalization. We propose the OptimNeuralTS strategy to efficiently mine claims datasets and build a predictive model of the association between drug combinations and health outcomes. Our method can detect up to 72% of PIPs while maintaining an average precision score of 99% using 30 000 time steps.
  arXiv  Detail & Related papers  (2022-12-10T03:43:23Z)
• RECOVER: sequential model optimization platform for combination drug repurposing identifies novel synergistic compounds in vitro [46.773794687622825]
  We employ a sequential model optimization search applied to a deep learning model to quickly discover highly synergistic drug combinations active against a cancer cell line. We find that the set of combinations queried by our model is enriched for highly synergistic combinations. Remarkably, we rediscovered a synergistic drug combination that was later confirmed to be under study within clinical trials.
  arXiv  Detail & Related papers  (2022-02-07T02:54:29Z)
• Machine Learning for Real-World Evidence Analysis of COVID-19 Pharmacotherapy [0.0]
  Real-world data generated from clinical practice can be used to analyze the real-world evidence of COVID-19 pharmacotherapy. Machine learning (ML) methods are being used and are promising tools for precision medicine. In this study, ML methods are applied to study the efficacy of therapies on COVID-19 hospital admissions in the Valencian Region of Spain.
  arXiv  Detail & Related papers  (2021-07-19T16:28:54Z)
• CovidDeep: SARS-CoV-2/COVID-19 Test Based on Wearable Medical Sensors and Efficient Neural Networks [51.589769497681175]
  The novel coronavirus (SARS-CoV-2) has led to a pandemic. The current testing regime based on Reverse Transcription-Polymerase Chain Reaction for SARS-CoV-2 has been unable to keep up with testing demands. We propose a framework called CovidDeep that combines efficient DNNs with commercially available WMSs for pervasive testing of the virus.
  arXiv  Detail & Related papers  (2020-07-20T21:47:28Z)
• Learning for Dose Allocation in Adaptive Clinical Trials with Safety Constraints [84.09488581365484]
  Phase I dose-finding trials are increasingly challenging as the relationship between efficacy and toxicity of new compounds becomes more complex. Most commonly used methods in practice focus on identifying a Maximum Tolerated Dose (MTD) by learning only from toxicity events. We present a novel adaptive clinical trial methodology that aims at maximizing the cumulative efficacies while satisfying the toxicity safety constraint with high probability.
  arXiv  Detail & Related papers  (2020-06-09T03:06:45Z)
• Predicting the risk of pancreatic cancer with a CT-based ensemble AI algorithm [0.0]
  Pancreatic cancer is a lethal disease, hard to diagnose and results in poor prognosis and high mortality. We propose an ensemble AI algorithm to predict universally cancer risk of all kinds of pancreatic lesions with noncontrast CT.
  arXiv  Detail & Related papers  (2020-04-03T06:06:43Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.